Medical nanotechnology 2017 Brochure

www.medicalnanotechnology.conferenceseries.com
Medical Nanotechnology 2017conferenceseries.com
Conference Secretariat
2360 Corporate Circle, Suite 400 Henderson, NV 89074-7722, USA
Ph: +1-650-268-9744, Fax: +1-650-618-1414, Toll free: +1-800-216-6499
Email: medicalnano@nanotechconferences.org
Brochure
15th
World Medical Nanotechnology
Congress
Osaka, Japan October 18-19, 2017

Medical Nanotechnology 2017 welcomes you to attend the 15th
World Medical Nanotechnology Congress
which is going to be held in Osaka, Japan during October 18-19, 2017.
We cordially invite all the participants who are interested in sharing their knowledge and research in the arena
of 15th World Medical Nanotechnology Congress.
Medical Nanotechnology 2017 anticipates more than 500 participants around the globe with thought provoking
Keynote lectures, Oral Presentations and Poster Presentations. The attending delegates include Editorial Board
Members of related International Journals.
This is an excellent opportunity for the delegates from Universities and Institutes to interact with the world class
Scientists.
The intending participants can confirm their participation by registering for the conference along with your
colleagues.
The main theme of the conference is “Advances of Nanomedicine in diagnosis theranostics”. Avail the delegate
early bird offer.
Regards,
Medical Nanotechnology 2017 Operating Committee
• Nanomedicine
• Nanoelectronics and Biomedical Devices
• DNA Nanotechnology
• Nano Pharmaceuticals
• Nanomedicine and Drug Delivery
• Nanotechnology in Cardiovascular Medicine
• Cancer Nanotechnology
• Nanotoxicity
• Graphene Nanomedicine
• Nanotechnology for Health care
• Nanotechnology for Pediatric Medicine
• Polymer Nanotechnology
• Advanced Nanomaterials
• NanoBiotechnology
• Nanotechnology and Cosmetics
• Biomaterials and Tissues Engineering
• Nano Computing
• Nanotechnology in Life Sciences & Medicine
• Recent developments in Nanotechnology
• Environment, Health and Safety Issues
Conference Highlights
Invitation

Welcome Message

Market Analysis
Summary of Medical Nanotechnology 2017 Conference:-
STUDY BACKGROUND
While it appears inevitable that nanotechnology will have a broad and fundamental impact
on many sectors of the U.S. economy, various technical, marketing and other hurdles need to
be overcome before nanotechnology fulfills this promise. These challenges and differences of
opinion regarding commercial applications are reflected in the widely diverging estimates of
the U.S. and global nanotechnology markets.
Estimates of the global nanotechnology market in 2010 range from about $15.7 billion (the
figure used in this report) to $1 trillion. By 2016, the market may be worth more than $2.4
trillion, according to different analysts. These differences reflect not only different analytical
methods and assumptions, but also different definitions of the nanotechnology market (e.g.,
whether to include decades-old technologies such as carbon black rubber reinforcers and
photographic silver, or whether to base the market value on nanotechnology inputs alone, as
opposed to the total value of products that incorporate nanotechnology).
Perhaps as a reflection of the difficulty of quantifying the market for nanotechnologies, some
analystsdownplaythecommercialdimensionsofthenanotechnologymarket,andfocusinstead
on the supply side, i.e., the development of new nanoscale technologies and applications. These
analysts have made valuable contributions, raising investors’ awareness of and interest in
nanotechnologies.
However, by itself, the work of these analysts does not provide sufficient information in order
to guide corporate or individual investment decisions. Investors require additional data, such
as the size of specific nanotechnology markets, prices, and competition, as well as potential
regulation.
STUDY GOALS AND OBJECTIVES
The goal of this report is to provide investors and others with information on the commercial
potential of various nanotechnologies and to complement the growing body of technical
information. Specific objectives include identifying segments of the nanotechnology market
withthegreatestcommercialpotentialintheneartomid-term(2010through2015),projecting
future demand in these segments, and evaluating the challenges that must be overcome
for each segment to realize its potential in order to estimate the probability of successful
commercialization.
INTENDED AUDIENCE
The report is especially intended for entrepreneurs, investors, venture capitalists, and other
readers with a need to know where the nanotechnology market is headed in the next 5 years.
Other readers who should find the report particularly valuable include nanotechnology
marketing executives and government officials associated with the National Nanotechnology
Initiative and other state-level programs that promote the development of the nanotechnology
industry. The report’s findings and conclusions should also be of interest to the broader
nanotechnology community.

Why Osaka?
Global Summit on Medical Nanotechnology is going to be held in Osaka, Japan. Osaka is the
second largest metropolitan area in Japan and serves a major economic hub. Historically a
merchant city, Osaka has also been known as the “Nation’s Kitchen”. With a population of 2.5
million, Osaka is Japan’s third largest and second most important city. It has been the economic
powerhouse of the Kansai region for many centuries. The city’s west side has the main port as
well as a tourist destination with attractions such as Kyocera Dome, Universal Studios Japan,
Osaka aquarium, Minami, Osaka castle, Umeda sky building and the TempozanHarbour Village.
The Museum of Oriental Ceramics holds more than 2,000 pieces of ceramics, from China, Korea,
Japan and Vietnam, featuring displays of some of their Korean celadon under natural light.
SCOPE OF REPORT
The new title on “Nanomedicine Market (Neurology, Cardiovascular, Anti-inflammatory, Anti-
infective, and Oncology Applications) - Global Industry Analysis, Size, Share, Growth, Trends
and Forecast, 2013 - 2019,” predicts that the total nanomedicine market globally will be worth
USD 177.60 billion by 2019, growing considerably from its 2012 value of USD 78.54 billion.
This market is expected to achieve a compounded annual growth rate of 12.3% between 2013
and 2019.
The report talks about the major growth areas of within the nanomedicine market over the period
of forecast. The introduction of new technologies and applications in this sector will propel growth
to a significant degree at the global level. Further, the initiatives taken by various governments
as well as privately-funded institutions towards promoting the commercialization of new
nanomedicine products will boost this market. The report also dwells on the role played by the
rising geriatric population base, the prevalence of medical needs that are in need of treatment, as
well as the rising incidence of chronic diseases globally.
Accordingtothereport,theleadingapplicationsegmentwithinthenanomedicinemarketwasthat
of oncology, holding a 38% share of the overall market in 2012, as a vast number of commercially
available products prevail in this sector.
The development of nanomedicine-based treatments and products that are able to directly target
tumors in the brain and other bodily sites is poised to be a significant factor affecting growth in
this market.
Thoughthelargestmarketsegmentwithinthenanomedicinemarketisthatofoncology,thefastest
growing segment is the cardiovascular market. According to the Transparency Market Research
report, growth in this segment has been fuelled by the presence of a sizeable patient population,
and a simultaneous growth in the demand for device and drugs that are based on nanomedicine.
These factors are collectively anticipated to further fuel the growth of the cardiovascular segment
within the nanomedicine market.
The report also carries out an in-depth analysis of the regional market share based on the
applications,revenue,andproducts.Accordingtothereport,thenanomedicinemarketwaslargely
dominated by North America in 2012. It is expected that this regional market will continue to
hold its leading position in the way over the forecast period until 2019.
Though the larger market share will be held by North America, it is anticipated that the fastest
growing market, by region, will be Asia-Pacific. The report states that the CAGR recorded by the
Asia-Pacific market will be 14.6% between 2013 and 2019.

Furthermore, the analysis of the regional markets also concludes that the Europe region is
predicted to show a growth rate that’s relatively higher than that of North America. Factors
that are likely to cause this increased growth rate include: an improvement in the regulatory
framework as well as the presence of a wide-ranging product portfolio in the pipeline, set to be
introduced by leading market players.
The report on the global nanomedicine market additionally comprises an overview of the key
market players in a section dedicated to company profiles. These key market players include
names such as: Abbott Laboratories, Merck & Co Inc, Pfizer Inc., GE Healthcare, Nanosphere
Inc., and many more.
Nanomedicine study in various countries:
GLOBAL MARKET
The emergence of nanomedicine and the application of nanomaterials in the healthcare industry
will bring about groundbreaking improvements to the current therapeutic and diagnostic
scenario.Someofthedriversofthismarketincludeincreasingresearchfunding,risinggovernment
support, improved regulatory framework, technological know-how and rising prevalence of
chronic diseases such as diabetes, cancers, obesity, kidney disorders, orthopedic diseases and
others.
The global nanomedicine market is categorized into six segments on the basis of application,
namely neurology, cardiovascular, anti-inflammatory, anti-infective, oncology and others.
Oncology held majority of the market share in 2012 on account of
following factors:
• Presence of high number of commercialized nanomedicine products in the market
• Improved bioavailability and efficacy of the tumor specific nanomedicine enabling targeted
drug delivery
• Rise in nanomedicine drug formulations replacing conventional drug formulations in cancer
treatment
However, the global market for cardiovascular segment is expected to grow at the fastest pace
owing to increasing prevalence of cardiovascular diseases demanding drugs with improved
efficacy and therapeutic properties. Furthermore, realizing the importance and benefits of
nanomedicine, researchers and manufacturers are striving to develop products with improved
therapeutic properties in the cardiovascular segment.
The North American nanomedicine market held the majority of global market share in 2012
because of the rapidly growing nanomedicine market in the Asia–Pacific, Latin American and
African region, presence of large number of patented nanomedicine products and favorable
regulatory framework in the region.In addition, the presence of sophisticated healthcare

Medical Nanotechnology 2017conferenceseries.cominfrastructure supports development of advanced products such as nano probes, nanorobots,
monoclonal antibody based immunoassays and nanoparticle based imaging agents for early
detection of diseases.
However, the Asia-Pacific region is expected to grow at a faster CAGR owing to presence of high
unmet healthcare needs, research collaborations and increase in nanomedicine research funding
in emerging economies such as China, India and other economies in the region.China is expected
to surpass the United States in terms of nanotechnology funding in the near future, which
indicates the growth offered by this region.
Overall research in various disciplines:
REPORT HIGHLIGHTS
The global Nanomedicine market reached $43.2 billion in 2010 and $50.1 billion in 2011. The
market is expected to grow to $96.9 billion by 2016 at a compound annual growth rate (CA GR)
of 14.1% between years 2011 and 2016.

International Journals
• 500 Open Access Journals
• 21 Day rapid review process
• 30000 Editorial team, 35000 Reviewers team
• 3.5 Million readers and high visibility
• More than 100000
• Publication immediately after acceptance
• Quality and quick editorial, review processing
Key features
• User friendly/feasible website translation of your paper to 50
world’s leading languages
• Enhanced feature: Audio version of published paper
• Digital articles to share and explore
• Sharing option: Social networking enabled
• Authors, reviewers and editors are provided with scientific
credits
Conference Series LLC
Conferences
• 300 Conferences all over the World every year
• Well organized scientific program
• Renowned speakers and scientists across the globe
• Poster presentations and world class exhibits
• Panel discussions and interactive sessions
• B2B meetings
• Perfect platform for Global Networking
Key features
• Presentation by renowned speakers from all over the world
• Poster presentations and world class exhibits
• Interactive Sessions
• Platform for global networking
• Connecting scientific community
Special Issues
All accepted abstracts will be published in respective International Journals
Each abstract will be provided with digital Object Identifier by
About Us

Shaker Mousa
Executive Vice President and Chairman
Pharmaceutical Research Institute
USA
Bharat Bhushan
Director
The Ohio State University
USA
Mary Mehrnoosh Eshaghian Wilner
Professor
University of Southern California
USA
Esmaiel Jabbari
Professor
University of South Carolina
USA
Hicham Fenniri
Professor
The Northeastern Supramolecular
Nanomaterials Lab
USA
Hussein Osman Ammar
Chairman
Faculty of Pharmacy
Future University in Egypt
Egypt
Der-Jang LIAW
Chair Professor
National Taiwan University of
Science and Technology
Taiwan
Aharon Gedanken
Senior Prof. (Emeritus)
Bar-Ilan Institute of
Nanotechnology and Advanced
Materials (BINA), Israel
Organizing Committee Members

15th
World Medical Nanotechnology Congress 2017 is the premier event that brings together a unique
and international mix of experts, researchers and decision makers both from academia and industry across
the globe to exchange their knowledge, expertise and research innovations to build a world class 15th
World Medical Nanotechnology Congress conference
The event focuses on aspects such as breeding, molecular marker development, crop/ trait improvement,
disease resistance, epigenetics, evolution studies and pathology as well understanding tools to overcome
barrierandenablesuccessfuldataanalysisandmanagement.Presentationsconcentratenotonlyparticular
to 15th World Medical Nanotechnology Congress but also crop and forestry research ranging from wheat,
barley, maize and rice to potato, tomato, arabidopsis, biofuels and various fruits.
Medical Nanotechnology 2017
• Opportunity to attend the presentations delivered by eminent scientists from all over the world
• Selected contributions will be published in following International Journals
• Journal of Nanomedicine & Nanotechnology
• Journal of Nanomaterials & Molecular Nanotechnology
• Journal of Nanomedicine & Biotherapeutic Discovery
• Participation in sessions on specific topics on which the conference is expected to achieve progress
• Global networking: In transferring and exchanging Ideas
• Share your excitement in promoting Health care, Clinical R & D
• ConferencebringstogetherScientificResearchers,BusinessEntrepreneursandPharma,Healthcare,IndustryDevelopers
Important Dates
Abstract submission deadline: May 29, 2017
Early bird registration: May 31, 2017
On spot registration: October 18, 2017
Venue
Hyatt Regency Osaka
1-13-11 Nanko-Kita, Suminoe-Ku
Osaka, Japan 559-0034.
Medical Nanotechnology 2017

Osaka is the second largest metropolitan area in Japan and serves a major economichub. Historically a merchant city,
Osaka has also been known as the “Nation’s Kitchen”. Witha population of 2.5 million, Osaka is Japan’s third largest and
second most important city. It hasbeen the economic powerhouse of the Kansai region for many centuries. The city’s west
side hasthe main port as well as a tourist destination with attractions such as Kyocera Dome, UniversalStudios Japan,
Osaka aquarium, Minami, Osaka castle, Umeda sky building and the TempozanHarbour Village.
Osaka is known for its food, both in Japan and abroad. Author Michael Boothand food critic François Simon of Le
Figaro have both suggested that Osaka is the food capitalof the world. Osaka’s culinary prevalence is the result of a
location that has provided access tohigh quality ingredients, a high population of merchants, and close proximity to the
ocean andwaterway trade. In recent years, Osaka has started to garner more attention from foreigners withthe increased
popularity of cooking and dining in popular culture.
About Osaka

Medical nanotechnology 2017 Brochure

Recommended

Recommended

More Related Content

What's hot

What's hot (14)

Similar to Medical nanotechnology 2017 Brochure

Similar to Medical nanotechnology 2017 Brochure (20)

More from Jasmin Keith

More from Jasmin Keith (8)

Recently uploaded

Recently uploaded (20)

Medical nanotechnology 2017 Brochure